NovoSeven RT and Semaglutide Subcutaneous
Determining the interaction of NovoSeven RT and Semaglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
Generic Name: semaglutide
Brand name: Ozempic, Rybelsus
Synonyms: Semaglutide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoSeven RT-Semaglutide Tablets
- NovoSeven RT-Semprex-D
- NovoSeven RT-Semprex-D Oral
- NovoSeven RT-Senatec Topical application
- NovoSeven RT-Senexon
- NovoSeven RT-Senexon-S
- Semaglutide Subcutaneous-NovoSeven RT with MixPro injection
- Semaglutide Subcutaneous-Novothyrox
- Semaglutide Subcutaneous-Noxafil
- Semaglutide Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- Semaglutide Subcutaneous-Noxafil (Posaconazole Injection)
- Semaglutide Subcutaneous-Noxafil (Posaconazole Oral Suspension)